Clinical Next-Generation Sequencing Panels Reveal Molecular Differences Between Merkel Cell Polyomavirus–Negative Merkel Cell Carcinomas and Neuroendocrine Carcinomas
American Journal of Clinical Pathology · 2023
DOI: 10.1093/ajcp/aqac176 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Clinical Pathology, 2023. Verfasst von Emily Hartsough und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. Hauptthemen laut MEDLINE: Carcinoma, Merkel Cell, Skin Neoplasms, Merkel cell polyomavirus, Tumor Virus Infections. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 62 Literaturangaben.
Abstract (Originalsprache)
Objectives
We aim to determine molecular differences between Merkel cell polyomavirus (MCPyV)–negative Merkel cell carcinomas (MCCs) and neuroendocrine carcinomas (NECs).
Methods
Our study included 56 MCCs (28 MCPyV negative, 28 MCPyV positive) and 106 NECs (66 small cell NECs, 21 large cell NECs, and 19 poorly differentiated NECs) submitted for clinical molecular testing.
Results
APC, MAP3K1, NF1, PIK3CA, RB1, ROS1, and TSC1 mutations, in addition to high tumor mutational burden and UV signature, were frequently noted in MCPyV-negative MCC in comparison to small cell NEC and all NECs analyzed, while KRAS mutations were more frequently noted in large cell NEC and all NECs analyzed. Although not sensitive, the presence of either NF1 or PIK3CA is specific for MCPyV-negative MCC. The frequencies of KEAP1, STK11, and KRAS alterations were significantly higher in large cell NEC. Fusions were detected in 6.25% (6/96) of NECs yet in none of 45 analyzed MCCs.
Conclusions
High tumor mutational burden and UV signature, as well as the presence of NF1 and PIK3CA mutations, are supportive of MCPyV-negative MCC, whereas KEAP1, STK11, and KRAS mutations are supportive of NEC in the appropriate clinical context. Although rare, the presence of a gene fusion is supportive of NEC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
ORCID-Profile: Mari Mino-Kenudson, Dora Dias-Santagata, Mai P Hoang
Zitieren
APA
Hartsough, E., Mino-Kenudson, M., Lennerz, J. K., Dias-Santagata, D., & Hoang, M. P. (2023). Clinical Next-Generation Sequencing Panels Reveal Molecular Differences Between Merkel Cell Polyomavirus–Negative Merkel Cell Carcinomas and Neuroendocrine Carcinomas. American Journal of Clinical Pathology. https://doi.org/10.1093/ajcp/aqac176
Vancouver
Hartsough E, Mino-Kenudson M, Lennerz JK, Dias-Santagata D, Hoang MP. Clinical Next-Generation Sequencing Panels Reveal Molecular Differences Between Merkel Cell Polyomavirus–Negative Merkel Cell Carcinomas and Neuroendocrine Carcinomas. American Journal of Clinical Pathology. 2023. doi:10.1093/ajcp/aqac176
BibTeX
@article{Hartsough2023,
author = {Hartsough, Emily and Mino-Kenudson, Mari and Lennerz, Jochen K and Dias-Santagata, Dora and Hoang, Mai P},
title = {Clinical Next-Generation Sequencing Panels Reveal Molecular Differences Between Merkel Cell Polyomavirus–Negative Merkel Cell Carcinomas and Neuroendocrine Carcinomas},
journal = {American Journal of Clinical Pathology},
year = {2023},
doi = {10.1093/ajcp/aqac176}
}
EUVIMED